NCT06358612

Brief Summary

Patients undergoing thyroid biopsy under local anesthetic will be asked to fill out a questionnaire that evaluates their anxiety level before and after their procedure. Patients will be randomly assigned to either use an anxiety reducing tool (stress balls in each hand) to take their mind off the procedure or will not receive an anxiety reducing tool.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 18, 2025

Status Verified

February 1, 2025

Enrollment Period

1.1 years

First QC Date

March 29, 2024

Last Update Submit

February 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in anxiety level of greater than 15% based on Visual Analog Score (VAS)

    The VAS is a simple and easy to administer test, and has been validated for the assessment of self-perceived psychological outcomes such as pain and anxiety. The VAS consists of a continuous 100 mm horizontal rating scale, along which subjects indicate with a tick the point that they feel best represents their state at a specified time, from "not at all anxious" at 0 mm to "extremely anxious" at 100 mm. For each response, a number from 0mm - 100mm will be measured, rounded to the nearest millimeter. In this study, subjects receive a pre-procedure questionnaire and post-procedure questionnaire consisting of VAS questions among other entries.

    1 year

Secondary Outcomes (5)

  • Changes in stress ball efficacy based on anxiety during "routine" medical procedures, using VAS

    1 year

  • Changes in stress ball efficacy based on self-perceived anxiety, using VAS

    1 year

  • Changes in stress ball efficacy based on age and sex, using questionnaire questions

    1 year

  • Subject self-perceived change in anxiety

    1 year

  • Subject opinion on helpful anxiety-reducing methods

    1 year

Study Arms (2)

Stress Balls

EXPERIMENTAL

Patients given a stress ball in each hand.

Other: Stress Balls

No Stress Balls

NO INTERVENTION

Patients NOT given a stress ball in each hand.

Interventions

Patients in the experimental arm will receive a foam stress ball to squeeze during their biopsy procedure.

Stress Balls

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18
  • Subjects undergoing thyroid biopsies under local anesthetic that can provide consent to treatment and for the research study.

You may not qualify if:

  • Previous biopsy experience
  • Greater than one (1) thyroid lesion requiring biopsy
  • Known allergy or sensitivity to stress ball material or cleaning solutions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nova Scotia Health

Halifax, Nova Scotia, Canada

RECRUITING

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Robert J Abraham, MD, FRCPC

    Nova Scotia Health Authority/Dalhousie University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Robert Abraham, MD, FRCPC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2024

First Posted

April 10, 2024

Study Start

December 1, 2024

Primary Completion

December 20, 2025

Study Completion

December 31, 2025

Last Updated

February 18, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations